aluates Reports

$ 0.0

Automative

Global Tumor Early Screening Products Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-32B7323

Global Tumor Early Screening Products Market Insights Forecast to 2028

BUY CHAPTERS

Global Tumor Early Screening Products Market Research Report 2025

Code: QYRE-Auto-32B7323

Report

July 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Exact Sciences

Epigenomics

Abbott

Oncognostic GmbH

New Horizon Health

GRAIL

Genetron Health

Burning Rock

Berry Oncology

Shanghai Kunyuan Biotechnology

Guardant Health

Freenome

iStat Biomedical

MBMbio

Tumor Early Screening Products Market Size

The global market for Tumor Early Screening Products was valued at US$ 831 million in the year 2024 and is projected to reach a revised size of US$ 1864 million by 2031, growing at a CAGR of 12.4% during the forecast period.

Tumor Early Screening Products Market

Tumor Early Screening Products refer to products for screening for early cancer and precancerous lesions for target populations who are apparently healthy and have not yet shown obvious abnormal symptoms

The market for tumor early screening products is rapidly evolving and expanding. With increasing awareness of the importance of early detection and advances in medical technology, there is a growing demand for effective screening tools to detect tumors at the earliest stages. The market size for these products is projected to be substantial and is expected to experience significant growth in the coming years. As research and development efforts continue, innovative technologies such as liquid biopsies, genomic testing, and artificial intelligence-based algorithms are being incorporated into tumor screening products, enhancing their accuracy and efficiency. Additionally, the integration of telemedicine and remote monitoring solutions is further driving the market"s growth, enabling easier access to screening services for individuals in remote areas. The future development of tumor early screening products holds promising prospects, with a focus on improving sensitivity, specificity, and cost-effectiveness. These advancements have the potential to revolutionize cancer care by enabling early detection, leading to better treatment outcomes and improved survival rates.

This report aims to provide a comprehensive presentation of the global market for Tumor Early Screening Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Early Screening Products.

The Tumor Early Screening Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Early Screening Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Early Screening Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tumor Early Screening Products Market Report

Report Metric	Details
Report Name	Tumor Early Screening Products Market
Accounted market size in year	US$ 831 million
Forecasted market size in 2031	US$ 1864 million
CAGR	12.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Liver Cancer Colorectal Cancer Lung Cancer Other
Segment by Application	Hospital Medical Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, MBMbio, Oncognostic, Epigenomics, Guardant Health, Freenome, Abbott, iStat Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Early Screening Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Tumor Early Screening Products Market growing?

Ans: The Tumor Early Screening Products Market witnessing a CAGR of 12.4% during the forecast period 2025-2031.

What is the Tumor Early Screening Products Market size in 2031?

Ans: The Tumor Early Screening Products Market size in 2031 will be US$ 1864 million.

Who are the main players in the Tumor Early Screening Products Market report?

Ans: The main players in the Tumor Early Screening Products Market are Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, MBMbio, Oncognostic, Epigenomics, Guardant Health, Freenome, Abbott, iStat Biomedical

What are the Application segmentation covered in the Tumor Early Screening Products Market report?

Ans: The Applications covered in the Tumor Early Screening Products Market report are Hospital, Medical Center, Other

What are the Type segmentation covered in the Tumor Early Screening Products Market report?

Ans: The Types covered in the Tumor Early Screening Products Market report are Liver Cancer, Colorectal Cancer, Lung Cancer, Other

Recommended Reports

Cancer Diagnostics

Tumor Detection

Cancer Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor Early Screening Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Liver Cancer

1.2.3 Colorectal Cancer

1.2.4 Lung Cancer

1.2.5 Other

1.3 Market by Application

1.3.1 Global Tumor Early Screening Products Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Medical Center

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tumor Early Screening Products Market Perspective (2020-2031)

2.2 Global Tumor Early Screening Products Growth Trends by Region

2.2.1 Global Tumor Early Screening Products Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tumor Early Screening Products Historic Market Size by Region (2020-2025)

2.2.3 Tumor Early Screening Products Forecasted Market Size by Region (2026-2031)

2.3 Tumor Early Screening Products Market Dynamics

2.3.1 Tumor Early Screening Products Industry Trends

2.3.2 Tumor Early Screening Products Market Drivers

2.3.3 Tumor Early Screening Products Market Challenges

2.3.4 Tumor Early Screening Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tumor Early Screening Products Players by Revenue

3.1.1 Global Top Tumor Early Screening Products Players by Revenue (2020-2025)

3.1.2 Global Tumor Early Screening Products Revenue Market Share by Players (2020-2025)

3.2 Global Tumor Early Screening Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tumor Early Screening Products Revenue

3.4 Global Tumor Early Screening Products Market Concentration Ratio

3.4.1 Global Tumor Early Screening Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor Early Screening Products Revenue in 2024

3.5 Global Key Players of Tumor Early Screening Products Head office and Area Served

3.6 Global Key Players of Tumor Early Screening Products, Product and Application

3.7 Global Key Players of Tumor Early Screening Products, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Early Screening Products Breakdown Data by Type

4.1 Global Tumor Early Screening Products Historic Market Size by Type (2020-2025)

4.2 Global Tumor Early Screening Products Forecasted Market Size by Type (2026-2031)

5 Tumor Early Screening Products Breakdown Data by Application

5.1 Global Tumor Early Screening Products Historic Market Size by Application (2020-2025)

5.2 Global Tumor Early Screening Products Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tumor Early Screening Products Market Size (2020-2031)

6.2 North America Tumor Early Screening Products Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Tumor Early Screening Products Market Size by Country (2020-2025)

6.4 North America Tumor Early Screening Products Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tumor Early Screening Products Market Size (2020-2031)

7.2 Europe Tumor Early Screening Products Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Tumor Early Screening Products Market Size by Country (2020-2025)

7.4 Europe Tumor Early Screening Products Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tumor Early Screening Products Market Size (2020-2031)

8.2 Asia-Pacific Tumor Early Screening Products Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Tumor Early Screening Products Market Size by Region (2020-2025)

8.4 Asia-Pacific Tumor Early Screening Products Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tumor Early Screening Products Market Size (2020-2031)

9.2 Latin America Tumor Early Screening Products Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Tumor Early Screening Products Market Size by Country (2020-2025)

9.4 Latin America Tumor Early Screening Products Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tumor Early Screening Products Market Size (2020-2031)

10.2 Middle East & Africa Tumor Early Screening Products Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Tumor Early Screening Products Market Size by Country (2020-2025)

10.4 Middle East & Africa Tumor Early Screening Products Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Exact Sciences

11.1.1 Exact Sciences Company Details

11.1.2 Exact Sciences Business Overview

11.1.3 Exact Sciences Tumor Early Screening Products Introduction

11.1.4 Exact Sciences Revenue in Tumor Early Screening Products Business (2020-2025)

11.1.5 Exact Sciences Recent Development

11.2 Grail

11.2.1 Grail Company Details

11.2.2 Grail Business Overview

11.2.3 Grail Tumor Early Screening Products Introduction

11.2.4 Grail Revenue in Tumor Early Screening Products Business (2020-2025)

11.2.5 Grail Recent Development

11.3 Genetron Health

11.3.1 Genetron Health Company Details

11.3.2 Genetron Health Business Overview

11.3.3 Genetron Health Tumor Early Screening Products Introduction

11.3.4 Genetron Health Revenue in Tumor Early Screening Products Business (2020-2025)

11.3.5 Genetron Health Recent Development

11.4 New Horizon Health

11.4.1 New Horizon Health Company Details

11.4.2 New Horizon Health Business Overview

11.4.3 New Horizon Health Tumor Early Screening Products Introduction

11.4.4 New Horizon Health Revenue in Tumor Early Screening Products Business (2020-2025)

11.4.5 New Horizon Health Recent Development

11.5 Burning Rock

11.5.1 Burning Rock Company Details

11.5.2 Burning Rock Business Overview

11.5.3 Burning Rock Tumor Early Screening Products Introduction

11.5.4 Burning Rock Revenue in Tumor Early Screening Products Business (2020-2025)

11.5.5 Burning Rock Recent Development

11.6 Berry Oncology

11.6.1 Berry Oncology Company Details

11.6.2 Berry Oncology Business Overview

11.6.3 Berry Oncology Tumor Early Screening Products Introduction

11.6.4 Berry Oncology Revenue in Tumor Early Screening Products Business (2020-2025)

11.6.5 Berry Oncology Recent Development

11.7 Shanghai Kunyuan Biotechnology

11.7.1 Shanghai Kunyuan Biotechnology Company Details

11.7.2 Shanghai Kunyuan Biotechnology Business Overview

11.7.3 Shanghai Kunyuan Biotechnology Tumor Early Screening Products Introduction

11.7.4 Shanghai Kunyuan Biotechnology Revenue in Tumor Early Screening Products Business (2020-2025)

11.7.5 Shanghai Kunyuan Biotechnology Recent Development

11.8 MBMbio

11.8.1 MBMbio Company Details

11.8.2 MBMbio Business Overview

11.8.3 MBMbio Tumor Early Screening Products Introduction

11.8.4 MBMbio Revenue in Tumor Early Screening Products Business (2020-2025)

11.8.5 MBMbio Recent Development

11.9 Oncognostic

11.9.1 Oncognostic Company Details

11.9.2 Oncognostic Business Overview

11.9.3 Oncognostic Tumor Early Screening Products Introduction

11.9.4 Oncognostic Revenue in Tumor Early Screening Products Business (2020-2025)

11.9.5 Oncognostic Recent Development

11.10 Epigenomics

11.10.1 Epigenomics Company Details

11.10.2 Epigenomics Business Overview

11.10.3 Epigenomics Tumor Early Screening Products Introduction

11.10.4 Epigenomics Revenue in Tumor Early Screening Products Business (2020-2025)

11.10.5 Epigenomics Recent Development

11.11 Guardant Health

11.11.1 Guardant Health Company Details

11.11.2 Guardant Health Business Overview

11.11.3 Guardant Health Tumor Early Screening Products Introduction

11.11.4 Guardant Health Revenue in Tumor Early Screening Products Business (2020-2025)

11.11.5 Guardant Health Recent Development

11.12 Freenome

11.12.1 Freenome Company Details

11.12.2 Freenome Business Overview

11.12.3 Freenome Tumor Early Screening Products Introduction

11.12.4 Freenome Revenue in Tumor Early Screening Products Business (2020-2025)

11.12.5 Freenome Recent Development

11.13 Abbott

11.13.1 Abbott Company Details

11.13.2 Abbott Business Overview

11.13.3 Abbott Tumor Early Screening Products Introduction

11.13.4 Abbott Revenue in Tumor Early Screening Products Business (2020-2025)

11.13.5 Abbott Recent Development

11.14 iStat Biomedical

11.14.1 iStat Biomedical Company Details

11.14.2 iStat Biomedical Business Overview

11.14.3 iStat Biomedical Tumor Early Screening Products Introduction

11.14.4 iStat Biomedical Revenue in Tumor Early Screening Products Business (2020-2025)

11.14.5 iStat Biomedical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Exact Sciences

Epigenomics

Abbott

Oncognostic GmbH

New Horizon Health

GRAIL

Genetron Health

Burning Rock

Berry Oncology

Shanghai Kunyuan Biotechnology

Guardant Health

Freenome

iStat Biomedical

MBMbio

List of Tables

Table 1. Global Tumor Early Screening Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Liver Cancer

Table 3. Key Players of Colorectal Cancer

Table 4. Key Players of Lung Cancer

Table 5. Key Players of Other

Table 6. Global Tumor Early Screening Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Tumor Early Screening Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Tumor Early Screening Products Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Tumor Early Screening Products Market Share by Region (2020-2025)

Table 10. Global Tumor Early Screening Products Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Tumor Early Screening Products Market Share by Region (2026-2031)

Table 12. Tumor Early Screening Products Market Trends

Table 13. Tumor Early Screening Products Market Drivers

Table 14. Tumor Early Screening Products Market Challenges

Table 15. Tumor Early Screening Products Market Restraints

Table 16. Global Tumor Early Screening Products Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Tumor Early Screening Products Market Share by Players (2020-2025)

Table 18. Global Top Tumor Early Screening Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Early Screening Products as of 2024)

Table 19. Ranking of Global Top Tumor Early Screening Products Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Tumor Early Screening Products Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Tumor Early Screening Products, Headquarters and Area Served

Table 22. Global Key Players of Tumor Early Screening Products, Product and Application

Table 23. Global Key Players of Tumor Early Screening Products, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Tumor Early Screening Products Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Tumor Early Screening Products Revenue Market Share by Type (2020-2025)

Table 27. Global Tumor Early Screening Products Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Tumor Early Screening Products Revenue Market Share by Type (2026-2031)

Table 29. Global Tumor Early Screening Products Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Tumor Early Screening Products Revenue Market Share by Application (2020-2025)

Table 31. Global Tumor Early Screening Products Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Tumor Early Screening Products Revenue Market Share by Application (2026-2031)

Table 33. North America Tumor Early Screening Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Tumor Early Screening Products Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Tumor Early Screening Products Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Tumor Early Screening Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Tumor Early Screening Products Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Tumor Early Screening Products Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Tumor Early Screening Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Tumor Early Screening Products Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Tumor Early Screening Products Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Tumor Early Screening Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Tumor Early Screening Products Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Tumor Early Screening Products Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Tumor Early Screening Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Tumor Early Screening Products Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Tumor Early Screening Products Market Size by Country (2026-2031) & (US$ Million)

Table 48. Exact Sciences Company Details

Table 49. Exact Sciences Business Overview

Table 50. Exact Sciences Tumor Early Screening Products Product

Table 51. Exact Sciences Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 52. Exact Sciences Recent Development

Table 53. Grail Company Details

Table 54. Grail Business Overview

Table 55. Grail Tumor Early Screening Products Product

Table 56. Grail Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 57. Grail Recent Development

Table 58. Genetron Health Company Details

Table 59. Genetron Health Business Overview

Table 60. Genetron Health Tumor Early Screening Products Product

Table 61. Genetron Health Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 62. Genetron Health Recent Development

Table 63. New Horizon Health Company Details

Table 64. New Horizon Health Business Overview

Table 65. New Horizon Health Tumor Early Screening Products Product

Table 66. New Horizon Health Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 67. New Horizon Health Recent Development

Table 68. Burning Rock Company Details

Table 69. Burning Rock Business Overview

Table 70. Burning Rock Tumor Early Screening Products Product

Table 71. Burning Rock Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 72. Burning Rock Recent Development

Table 73. Berry Oncology Company Details

Table 74. Berry Oncology Business Overview

Table 75. Berry Oncology Tumor Early Screening Products Product

Table 76. Berry Oncology Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 77. Berry Oncology Recent Development

Table 78. Shanghai Kunyuan Biotechnology Company Details

Table 79. Shanghai Kunyuan Biotechnology Business Overview

Table 80. Shanghai Kunyuan Biotechnology Tumor Early Screening Products Product

Table 81. Shanghai Kunyuan Biotechnology Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 82. Shanghai Kunyuan Biotechnology Recent Development

Table 83. MBMbio Company Details

Table 84. MBMbio Business Overview

Table 85. MBMbio Tumor Early Screening Products Product

Table 86. MBMbio Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 87. MBMbio Recent Development

Table 88. Oncognostic Company Details

Table 89. Oncognostic Business Overview

Table 90. Oncognostic Tumor Early Screening Products Product

Table 91. Oncognostic Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 92. Oncognostic Recent Development

Table 93. Epigenomics Company Details

Table 94. Epigenomics Business Overview

Table 95. Epigenomics Tumor Early Screening Products Product

Table 96. Epigenomics Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 97. Epigenomics Recent Development

Table 98. Guardant Health Company Details

Table 99. Guardant Health Business Overview

Table 100. Guardant Health Tumor Early Screening Products Product

Table 101. Guardant Health Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 102. Guardant Health Recent Development

Table 103. Freenome Company Details

Table 104. Freenome Business Overview

Table 105. Freenome Tumor Early Screening Products Product

Table 106. Freenome Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 107. Freenome Recent Development

Table 108. Abbott Company Details

Table 109. Abbott Business Overview

Table 110. Abbott Tumor Early Screening Products Product

Table 111. Abbott Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 112. Abbott Recent Development

Table 113. iStat Biomedical Company Details

Table 114. iStat Biomedical Business Overview

Table 115. iStat Biomedical Tumor Early Screening Products Product

Table 116. iStat Biomedical Revenue in Tumor Early Screening Products Business (2020-2025) & (US$ Million)

Table 117. iStat Biomedical Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Tumor Early Screening Products Picture

Figure 2. Global Tumor Early Screening Products Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tumor Early Screening Products Market Share by Type: 2024 VS 2031

Figure 4. Liver Cancer Features

Figure 5. Colorectal Cancer Features

Figure 6. Lung Cancer Features

Figure 7. Other Features

Figure 8. Global Tumor Early Screening Products Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Tumor Early Screening Products Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Medical Center Case Studies

Figure 12. Other Case Studies

Figure 13. Tumor Early Screening Products Report Years Considered

Figure 14. Global Tumor Early Screening Products Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Tumor Early Screening Products Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Tumor Early Screening Products Market Share by Region: 2024 VS 2031

Figure 17. Global Tumor Early Screening Products Market Share by Players in 2024

Figure 18. Global Top Tumor Early Screening Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Early Screening Products as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Tumor Early Screening Products Revenue in 2024

Figure 20. North America Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Tumor Early Screening Products Market Share by Country (2020-2031)

Figure 22. United States Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Tumor Early Screening Products Market Share by Country (2020-2031)

Figure 26. Germany Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Tumor Early Screening Products Market Share by Region (2020-2031)

Figure 34. China Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Tumor Early Screening Products Market Share by Country (2020-2031)

Figure 42. Mexico Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Tumor Early Screening Products Market Share by Country (2020-2031)

Figure 46. Turkey Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Tumor Early Screening Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Exact Sciences Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 50. Grail Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 51. Genetron Health Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 52. New Horizon Health Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 53. Burning Rock Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 54. Berry Oncology Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 55. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 56. MBMbio Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 57. Oncognostic Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 58. Epigenomics Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 59. Guardant Health Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 60. Freenome Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 61. Abbott Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 62. iStat Biomedical Revenue Growth Rate in Tumor Early Screening Products Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Cancer Early Detection and Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Early Detection Market Research Report 2025

Blood Cancer Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Tracking System Market Insights Forecast to 2030

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global Mobile Cancer Screening Devices Market Insights Forecast to 2030

Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Natural Health Products Market Insights Forecast to 2030

Tumor Blood Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Health Check Software Market Insights Forecast to 2030

Global Prostate Cancer Market Insights Forecast to 2030

In Vitro Colorectal Cancer Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rapid Cancer Tests Market Insights Forecast to 2030

Global Breast Cancer Screening Market Research Report 2025

Astaxanthin Gummies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Cancer and Gastric Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Cancer and Gastric Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Detection Services Market Research Report 2024

Calcium Gummies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions